Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroshi Suzu is active.

Publication


Featured researches published by Hiroshi Suzu.


The Journal of Urology | 1984

Carcinosarcoma of the Bladder

Yasuyuki Kusaba; Yoshiaki Yushita; Hiroshi Suzu; Akihito Jodai; Shuji Yamashita; Hiroshi Kanetake; Kazuhiko Shindo; Yutaka Saito

We report a case of carcinosarcoma of the bladder. Total cystectomy with ileal loop urinary diversion was performed. Histologically, the bulk of the tumor tissue was rhabdomyosarcoma and adenocarcinoma. At distant areas from the bulk tumor transitional cell carcinoma was noted. The literature is reviewed and the clinicopathologic condition of carcinosarcoma of the bladder is discussed.


Japanese Journal of Cancer Research | 1992

Novel Complications with HTLV‐1‐associated Myelopathy/Tropical Spastic Paraparesis: Interstitial Cystitis and Persistent Prostatitis

Koichiro Nomata; Tatsufumi Nakamura; Hiroshi Suzu; Yoshiaki Yushita; Hiroshi Kanetake; Takashi Sawada; Shu-ichi Ikeda; Shigeo Hino; Shigenobu Nagataki; Yutaka Saito

Lower urinary symptoms associated with HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSF) are common, but have been regarded as ‘neurogenic’ due to spinal involvements. However, in some cases, these symptoms are persistent, progressive, and not directly correlated with the severity of other neurologic symptoms of the lower spinal cord. These findings prompted us to locate organic lesions in the lower urinary tract and to correlate them with HTLV‐1 infection. Among 35 HAM patients with lower urinary symptoms, we found 4 cases with the symptoms persistent and progressive: 3 with contracted bladder and another with persistent prostatitis. Histological or cytological examinations indicated local lymphocytic infiltrations in the lower urinary tract in all cases: 3 by the infiltration in the bladder and the other by a high concentration of lymphocytes in expressed prostatic secretions. Of 3 cases whose urinary samples were available, 2 showed significant increase in the concentration of urinary anti‐HTLV‐1 antibody of IgA class. The urinary IgA antibody of the third case was not elevated, but the sample had been obtained after resection of the affected bladder. None of the control cases showed significant anti‐HTLV‐1 IgA antibody in urine except for a case of gross hematuria due to chemotherapy directed against adult T‐cell leukemia. We suggest inclusion of these processes into the spectrum of complications for HAM/TSP. The elevated excretion of anti‐HTLV‐1 of IgA class in urine may be an indicator of these complications.


Urologia Internationalis | 1999

Paraganglioma of the Urinary Bladder: A Case Report and Review of the Japanese Literature

Takefumi Shono; Hideki Sakai; Yuzo Minami; Hiroshi Suzu; Hiroshi Kanetake; Yutaka Saito

We describe a patient with primary paraganglioma of the urinary bladder associated with typical clinical symptoms. Systolic blood pressure frequently increased to 300 mm Hg immediately after micturition. Levels of urinary vanillylmandelic acid excretion and serum norepinephrine were significantly elevated. The tumor was removed by partial cystectomy. Histological examination of the tumor revealed paraganglioma of the urinary bladder. Compared with a review of 53 similar cases reported in Japan, the distribution of age, sex and tumor location in the bladder differed from those described worldwide.


Urologia Internationalis | 1990

A case of deoxycorticosterone-producing benign adrenocortical tumor

Pabitra Kumar Saha; Toshio Ura; Hiroshi Suzu; Shuzi Yamashita; Yoshiaki Yushita; Hiroshi Kanetake; Yutaka Saito; Hideo Tsuchiyama; Kazuto Shigematsu; Souitsu Hukuzi; Motoko Kozima

A case of deoxycorticosterone-producing benign adrenocortical tumor is presented. A review of the English literature revealed that this is the second case of deoxycorticosterone-producing adrenocortical adenoma.


Journal of the Neurological Sciences | 2001

Neurogenic bladder in Lambert–Eaton myasthenic syndrome and its response to 3,4-diaminopyridine

Katsuya Satoh; Masakatsu Motomura; Hiroshi Suzu; Yoko Nakao; Takeshi Fujimoto; Taku Fukuda; Shunya Nakane; Tatsufumi Nakamura; Katsumi Eguchi

Autonomic dysfunction, as well as neuromuscular involvement, is a common manifestation of Lambert-Eaton myasthenic syndrome (LEMS). Dry mouth and impotence have been described as typical features of autonomic dysfunction, but neurogenic bladder is infrequent or subclinical in LEMS. We report a patient with neurogenic bladder secondary to LEMS whose condition responded to 3,4-diaminopyridine (3,4-DAP). In this patients serum, results of repeated measurement with P/Q-type VGCC antibodies proved positive, but not with N-type VGCC and synaptotagmin antibodies. A review of the literature turned up a few patients with voiding dysfunction related to LEMS, but no urodynamic studies were done on these patients. Ours is the first case in which 3,4-DAP was efficacious in treating LEMS and neurogenic bladder. Responses of 3,4-DAP in urodynamic studies suggest that in this LEMS patient neurogenic bladder was caused by defective neurotransmission both in the autonomic detrusor and skeletal abdominal muscles.


Urologia Internationalis | 1989

A Case of Spontaneous Rupture of Ureter due to Ureteral Stone in G Syndrome

Pabitra Kumar Saha; Toshio Ura; Hiroshi Suzu; Shuji Yamashita; Hiroshi Kanetake; Kazuhiko Shindo; Tsutomu Sakai; Yutaka Saito

A case of spontaneous rupture of ureter with formation of urinoma due to ureteral stone, which was noticed in an infant with G syndrome, is described. Investigation revealed that the patient had bilateral vesicoureteric reflux. The urinary tract anomalies in G syndrome are discussed.


International Urology and Nephrology | 1992

Segmental stenosis of ureter: A late complication of intra-arterial chemotherapy for bladder cancer

Pabitra Kumar Saha; Keisuke Taniguchi; N. Maekawa; Hiroshi Suzu; Shuji Yamashita; Hiroshi Kanetake; Yutaka Saito

A 54-year-old Japanese male was treated with a single shot of cisplatin-phosphatidylcholine-lipiodol (CPL) suspension dut to bladder tumour (stage T2N0M0). Seven months later, a right lower ureteral stenosis developed. The possible cause of ureteral stenosis due to intra-arterial chemotherapy is discussed.


The Japanese Journal of Urology | 1991

HTLV-I Associated Myelopathy (HAM) に随伴してみとめられた膀胱病変の検討

Koichiro Nomata; Hiroshi Suzu; Yoshiaki Yushita; Hiroshi Kanetake; Yutaka Saito


西日本泌尿器科 | 1997

CLINICAL EVALUATION OF THE EFFICACY OF URAPIDIL AND DISTIGMINE BROMIDE FOR VOIDING DYSFUNCTION DUE TO NEUROGENIC BLADDER

Joichi Kumazawa; Yasusuke Kimoto; Hiroshi Yamashita; Kenji Ito; Hiromi Kawano; Shinshi Noda; Masanori Noguchi; Osamu Yoshizumi; Yuji Oyabu; Zenjiro Masaki; Kaoru Miyazaki; Koji Nakamura; Yutaka Saito; Hiroshi Suzu; Manabu Matsuo; Yukio Osada; Takanori Yamaguchi; Yoshitada Ohi; Toshihiro Goto; Kazuya Kawahara; Tetsushi Matsusako; Akira Imamura; Yoshihide Ogawa; Tadashi Hatano; Yuzo Koyama; Masahide Jahana; Hiroyuki Yono; Yoshiro Sawae


The Japanese Journal of Urology | 1991

Bladder replacement with sigmoid colon for bladder cancer

Nishimura N; Hiroshi Suzu; Yoshiaki Yushita; Shuji Yamashita; Hiroshi Kanetake; Yutaka Saito; Sakuragi T

Collaboration


Dive into the Hiroshi Suzu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tatsufumi Nakamura

Nagasaki International University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge